R&D How to optimise commercial-scale ATMP manufacturing through ... This is the second part of our series, "The ATMP Manufacturer's Guide to Commercialisation and cGMP Compliance".
R&D How to transition from lab to commercial-scale ATMP Manufact... This is the first article of our series, “The ATMP Manufacturer’s Guide to Commercialisation and cGMP Compliance”.
News NHS "isn't delivering equitable care for rare diseases" A Genetic Alliance UK report claims the NHS is failing to meet the needs of many of the 3.5 million people in the country who live with rare diseases.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.
